[Vitamin D. II. Clinico-therapeutic implications].
Farrerons Minguella
J
J
González Sastre
F
F
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000209:etiology; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D004032:Diet; D006801:Humans; D006887:Hydroxycholecalciferols / Q000378:metabolism; D007015:Hypophosphatemia, Familial / Q000188:drug therapy; D008107:Liver Diseases / Q000150:complications; D008286:Malabsorption Syndromes / Q000150:complications / Q000378:metabolism; D009369:Neoplasms / Q000150:complications / Q000378:metabolism; D010018:Osteomalacia / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D010024:Osteoporosis / Q000188:drug therapy / Q000378:metabolism; D010279:Parathyroid Diseases / Q000150:complications / Q000378:metabolism; D011183:Postoperative Complications / Q000378:metabolism; D018167:Receptors, Calcitriol; D011987:Receptors, Steroid / Q000378:metabolism; D012279:Rickets / Q000151:congenital / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism / Q000627:therapeutic use*; D014808:Vitamin D Deficiency / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D000927:Anticonvulsants; D006887:Hydroxycholecalciferols; D018167:Receptors, Calcitriol; D011987:Receptors, Steroid; D014807:Vitamin D
Vitamina D (II): Implicaciones clínico-terapéuticas.